The U.S. Food and Drug Administration (FDA) has announced a recall of epinephrine injection products, citing a potential for the devices to malfunction during an emergency. Epinephrine is a critical, life-saving medication used to treat severe allergic reactions, known as anaphylaxis. According to the agency, the recall was initiated because the product may fail to deliver the necessary dose, which could lead to fatal consequences for patients experiencing a severe allergic reaction.

The FDA is urging all consumers, pharmacies, and medical facilities to check their current inventory for the affected lot numbers. Those in possession of the recalled units are instructed to stop using the product immediately and either discard it according to local regulations or return it to the point of purchase for a replacement or refund. While the recall notice highlights the severity of the potential failure, it emphasizes that patients should ensure they have a functional epinephrine auto-injector available at all times. The agency has not yet provided a comprehensive list of every affected brand or manufacturer in this specific notice, focusing instead on the immediate safety protocol for those currently holding the devices.